Shinji Tanaka

Tokyo Medical and Dental University — Japan

Medicine · Health Sciences

53h-index9.9kcitations452works1.52yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Pancreatic and Hepatic Oncology Research(62), Hepatocellular Carcinoma Treatment and Prognosis(39), RNA modifications and cancer(39), Cholangiocarcinoma and Gallbladder Cancer Studies(28), Ferroptosis and cancer prognosis(26)

Publications452 total

Clinicopathological features and prognosis of metastatic tumors in the small bowel: a large multicenter analysis of the JSCCR database in Japan
Journal of Gastroenterology·2025· 1 citedOpen Access
Supplementary Methods from PAD2-Mediated Histone Citrullination Drives Tumor Progression by Enhancing Cell Proliferation and Modifying the Microenvironment in Pancreatic Cancer
2025Open Access
Supplementary Figure S7 from PAD2-Mediated Histone Citrullination Drives Tumor Progression by Enhancing Cell Proliferation and Modifying the Microenvironment in Pancreatic Cancer
2025Open Access
Supplementary Table S8 from PAD2-Mediated Histone Citrullination Drives Tumor Progression by Enhancing Cell Proliferation and Modifying the Microenvironment in Pancreatic Cancer
2025Open Access
Supplementary Figure S5 from PAD2-Mediated Histone Citrullination Drives Tumor Progression by Enhancing Cell Proliferation and Modifying the Microenvironment in Pancreatic Cancer
2025Open Access
Supplementary Table S3 from PAD2-Mediated Histone Citrullination Drives Tumor Progression by Enhancing Cell Proliferation and Modifying the Microenvironment in Pancreatic Cancer
2025Open Access
Supplementary Figure S6 from PAD2-Mediated Histone Citrullination Drives Tumor Progression by Enhancing Cell Proliferation and Modifying the Microenvironment in Pancreatic Cancer
2025Open Access
Supplementary Table S2 from PAD2-Mediated Histone Citrullination Drives Tumor Progression by Enhancing Cell Proliferation and Modifying the Microenvironment in Pancreatic Cancer
2025Open Access
Supplementary Table S7 from PAD2-Mediated Histone Citrullination Drives Tumor Progression by Enhancing Cell Proliferation and Modifying the Microenvironment in Pancreatic Cancer
2025Open Access
Supplementary Table S5 from PAD2-Mediated Histone Citrullination Drives Tumor Progression by Enhancing Cell Proliferation and Modifying the Microenvironment in Pancreatic Cancer
2025Open Access
Supplementary Table S1 from PAD2-Mediated Histone Citrullination Drives Tumor Progression by Enhancing Cell Proliferation and Modifying the Microenvironment in Pancreatic Cancer
2025Open Access
Supplementary Figure S9 from PAD2-Mediated Histone Citrullination Drives Tumor Progression by Enhancing Cell Proliferation and Modifying the Microenvironment in Pancreatic Cancer
2025Open Access
Supplementary Table S6 from PAD2-Mediated Histone Citrullination Drives Tumor Progression by Enhancing Cell Proliferation and Modifying the Microenvironment in Pancreatic Cancer
2025Open Access
Supplementary Figure S8 from PAD2-Mediated Histone Citrullination Drives Tumor Progression by Enhancing Cell Proliferation and Modifying the Microenvironment in Pancreatic Cancer
2025Open Access
Supplementary Figure S4 from PAD2-Mediated Histone Citrullination Drives Tumor Progression by Enhancing Cell Proliferation and Modifying the Microenvironment in Pancreatic Cancer
2025Open Access
Supplementary Figure S3 from PAD2-Mediated Histone Citrullination Drives Tumor Progression by Enhancing Cell Proliferation and Modifying the Microenvironment in Pancreatic Cancer
2025Open Access
Data from PAD2-Mediated Histone Citrullination Drives Tumor Progression by Enhancing Cell Proliferation and Modifying the Microenvironment in Pancreatic Cancer
2025Open Access
Supplementary Table S9 from PAD2-Mediated Histone Citrullination Drives Tumor Progression by Enhancing Cell Proliferation and Modifying the Microenvironment in Pancreatic Cancer
2025Open Access
Supplementary Figure S1 from PAD2-Mediated Histone Citrullination Drives Tumor Progression by Enhancing Cell Proliferation and Modifying the Microenvironment in Pancreatic Cancer
2025Open Access
Supplementary Table S4 from PAD2-Mediated Histone Citrullination Drives Tumor Progression by Enhancing Cell Proliferation and Modifying the Microenvironment in Pancreatic Cancer
2025Open Access
page 1 of 23Next →

Frequent Co-authors

Shigeki Arii(19), Atsushi Kudo(12), Jack R. Wands(10), Yusuke Mitsunori(8), Daisuke Ban(8), Keizō Sugimachi(7), Minoru Tanabe(7), Arihiro Aihara(7), Kaoru Mogushi(6), Takanori Ochiai(6), Satoshi Matsumura(6), Mitsuo Shimada(5), Shu Shimada(5), Masaki Mori(5), Noriaki Nakamura(5), Johji Inazawa(4), Ken Shirabe(4), Yoshimitsu Akiyama(4), K Sugimachi(4), Shoji Yamaoka(4)